On the move all over the world.
For surgeons and patients.

Osteosynthesis company

As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland. For optimized treatment and an improved quality of life for patients. Worldwide.

founded1997

employees worldwide650

Subsidiaries13

sales partners50

million CHF net sales in 2020125

« Medartis stands for Swiss engineered, high-tech innovation that addresses unmet clinical needs. We are passionate about developing advanced implant solutions for medical professionals with the aim of improving patient’s treatment and restore their quality of life. »

Christoph Brönnimann
Chief Executive Officer
Member of the Executive Management Board

Making history in osteosynthesis.

With the foundation of Medartis in 1997, Dr. h.c. Thomas Straumann laid the cornerstone for our current strong position in implants for cranio-maxillofacial surgery and the extremities. That was just the beginning. Because we're moving on. And making history in osteosynthesis.

1954

Foundation of Institut Straumann AG by Prof. Dr. Reinhard Straumann. Specialisation in metallurgy for the watchmaking industry.

1960

Merger of metallurgy and medicine by Dr. h.c. Fritz Straumann.

1989

Sale of the Osteosynthesis Division to Stratec Medical (Straumann Technology, today Synthes J&J).

1990

Spin-off of the dental division of Straumann AG by Dr. h.c. Thomas Straumann.

1997

Foundation of Medartis AG with headquarters in Basel/Switzerland by Dr. h.c. Thomas Straumann. Acquisition of a small, independent specialist for oral and maxillofacial surgery and further development of the portfolio.

2002

Start of the establishment of our own sales organisation and commencement of the development of the next generation of osteosynthesis technologies by experienced innovators.

2004

Introduction of the TriLock^® locking technology. Entry into the area of the upper extremities with hand and wrist systems.

2005

Establishment of production at the new Bretzwil plant.

2007

Awarded with the SME Entrepreneur Prize Northwestern Switzerland.

2009

Medartis under one roof. Relocation of all parts of the company (administration, development, sales, production) to the new headquarters in the Stücki Business Park (Basel).

2010

Entry into the fields of foot and elbow surgery.

2011

Introduction of cannulated compression screws 2.2 and 3.0.

2012

Introduction of the arthrodesis system.

2013

Introduction of the orthognathic system and completion of the elbow system.

2015

Winner of the Prix SVC Northern Switzerland.

Introduction of a new generation of implants for the wrist.

2016

Start of the focus on lower extremities with the introduction of new foot and ankle systems.
Willi Miesch receives the award “Ernst & Young Entrepreneur of the Year” in the Industry/High-tech/Life Sciences category.

2017

Acquisition of the Mimedis company, active in pre-operative planning and 3D printing of patient-specific implants.

2018

Initial public offering on the SIX Swiss Exchange.

Competence and experience

The Executive Management Board of Medartis.

Christoph Brönnimann

Chief Executive Officer

On the move all over the world. For surgeons and patients.